HYDROXAMIC ACID COMPOUND CONTAINING QUINOLYL AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THIS COMPOUND AND USE THEREOF

(19)

(11)

EP 2 769 976 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	13.12.2017 Bulletin 2017/50

(45)	Mention of the grant of the patent:
	02.08.2017 Bulletin 2017/31

(21)	Application number: 11872645.4

(22)	Date of filing: 27.09.2011

(51)

International Patent Classification (IPC):

C07D 401/12^(2006.01)
A61K 31/4709^(2006.01)
A61P 17/06^(2006.01)
A61P 3/10^(2006.01)
A61P 37/02^(2006.01)
A61P 25/00^(2006.01)
A61P 25/28^(2006.01)
A61P 25/16^(2006.01)
A61P 35/02^(2006.01)

C07D 215/233^(2006.01)
A61K 31/47^(2006.01)
A61P 1/16^(2006.01)
A61P 27/02^(2006.01)
A61P 9/00^(2006.01)
A61P 25/08^(2006.01)
A61P 25/14^(2006.01)
A61P 35/00^(2006.01)

(86)	International application number:
	PCT/CN2011/080213

(87)	International publication number:
	WO 2013/040801 (28.03.2013 Gazette 2013/13)

(54)

HYDROXAMIC ACID COMPOUND CONTAINING QUINOLYL AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THIS COMPOUND AND USE THEREOF

HYDROXAMSÄUREVERBINDUNG MIT CHINOLYL UND HERSTELLUNGSVERFAHREN DAFÜR SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DIESER VERBINDUNG UND VERWENDUNG DAVON

COMPOSÉ D'ACIDE HYDROXAMIQUE CONTENANT DE LA QUINOLYLE ET PROCÉDÉ DE PRÉPARATION ASSOCIÉ, ET COMPOSITION PHARMACEUTIQUE CONTENANT CE COMPOSÉ ET UTILISATION ASSOCIÉE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

19.09.2011 CN 201110278403

(43)	Date of publication of application:
	27.08.2014 Bulletin 2014/35

(73)	Proprietor: Beijing Konruns Pharmaceutical Co., Ltd.
	Beijing 100085 (CN)

(72)	Inventors:
	YUN, Ziwei Guangzhou Guangdong 510663 (CN) WANG, Hongtao Guangzhou Guangdong 510663 (CN)

(74)	Representative: Brosch, Oliver et al
	Kutzenberger Wolff & Partner Theodor-Heuss-Ring 23 50668 Köln 50668 Köln (DE)

(56)

References cited: :

WO-A2-2005/030140
CN-A- 1 839 121

CN-A- 1 228 083
US-A1- 2008 221 132

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).